Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BDH INDUS. vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BDH INDUS. PANACEA BIOTECH BDH INDUS./
PANACEA BIOTECH
 
P/E (TTM) x 18.8 -60.5 - View Chart
P/BV x 3.0 0.9 346.7% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 BDH INDUS.   PANACEA BIOTECH
EQUITY SHARE DATA
    BDH INDUS.
Mar-23
PANACEA BIOTECH
Mar-23
BDH INDUS./
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs211191 110.4%   
Low Rs93107 86.3%   
Sales per share (Unadj.) Rs129.375.1 172.1%  
Earnings per share (Unadj.) Rs14.2-5.5 -258.6%  
Cash flow per share (Unadj.) Rs15.20.9 1,734.6%  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %2.60-  
Book value per share (Unadj.) Rs95.0137.7 68.9%  
Shares outstanding (eoy) m5.7661.25 9.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.22.0 59.1%   
Avg P/E ratio x10.7-27.1 -39.3%  
P/CF ratio (eoy) x10.0170.0 5.9%  
Price / Book Value ratio x1.61.1 147.5%  
Dividend payout %28.10-   
Avg Mkt Cap Rs m8749,142 9.6%   
No. of employees `000NANA-   
Total wages/salary Rs m701,265 5.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7454,599 16.2%  
Other income Rs m8517 1.6%   
Total revenues Rs m7535,116 14.7%   
Gross profit Rs m11047 232.9%  
Depreciation Rs m6391 1.5%   
Interest Rs m244 3.6%   
Profit before tax Rs m111128 86.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m29466 6.2%   
Profit after tax Rs m82-337 -24.3%  
Gross profit margin %14.71.0 1,439.0%  
Effective tax rate %25.9363.5 7.1%   
Net profit margin %11.0-7.3 -150.2%  
BALANCE SHEET DATA
Current assets Rs m6055,623 10.8%   
Current liabilities Rs m2463,297 7.5%   
Net working cap to sales %48.250.6 95.3%  
Current ratio x2.51.7 144.1%  
Inventory Days Days359 4.3%  
Debtors Days Days81648 1,710.7%  
Net fixed assets Rs m1957,028 2.8%   
Share capital Rs m5861 94.0%   
"Free" reserves Rs m4898,375 5.8%   
Net worth Rs m5478,436 6.5%   
Long term debt Rs m0202 0.0%   
Total assets Rs m80012,712 6.3%  
Interest coverage x71.13.9 1,828.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.4 257.1%   
Return on assets %10.4-2.3 -453.2%  
Return on equity %15.0-4.0 -375.0%  
Return on capital %20.52.0 1,028.2%  
Exports to sales %51.743.3 119.3%   
Imports to sales %29.724.4 121.7%   
Exports (fob) Rs m3851,992 19.3%   
Imports (cif) Rs m2211,124 19.7%   
Fx inflow Rs m3851,992 19.3%   
Fx outflow Rs m2211,191 18.6%   
Net fx Rs m163801 20.4%   
CASH FLOW
From Operations Rs m63-4,225 -1.5%  
From Investments Rs m54,303 0.1%  
From Financial Activity Rs m4-184 -2.0%  
Net Cashflow Rs m71-105 -68.1%  

Share Holding

Indian Promoters % 41.6 73.6 56.5%  
Foreign collaborators % 8.1 0.0 -  
Indian inst/Mut Fund % 0.0 1.0 -  
FIIs % 0.0 0.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 26.4 190.6%  
Shareholders   5,111 47,091 10.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BDH INDUS. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BDH INDUS. vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BDH INDUS. vs Panacea Biotech Share Price Performance

Period BDH INDUS. Panacea Biotech S&P BSE HEALTHCARE
1-Day -1.35% -2.47% 1.18%
1-Month -3.05% -20.61% -0.75%
1-Year 162.61% 10.92% 61.82%
3-Year CAGR 46.30% -12.48% 18.16%
5-Year CAGR 30.29% -10.11% 19.79%

* Compound Annual Growth Rate

Here are more details on the BDH INDUS. share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of BDH INDUS. hold a 49.7% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BDH INDUS. and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, BDH INDUS. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 28.1%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of BDH INDUS., and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.